• Press Release

Harren Jhoti receives BIA Lifetime Achievement Award at Annual Gala Dinner

Harren Jhoti, co-founder of Astex and President and CEO of Astex Pharmaceuticals, was awarded the BioIndustry Association (BIA) Lifetime Achievement Award at the BIA’s annual Gala Dinner last night.

New report reveals UK has the strongest R&D pipeline in Europe and the UK sector is maturing

‘Pipeline Progressing: the UK’s global bioscience cluster in 2017’ launched by the BioIndustry Association and Informa Pharma Intelligence

The State of the Drug Discovery Nation unveiled as new report provides vital insights for the development of new medicines

The Medicines Discovery Catapult and BioIndustry Association call on the R&D community to address five themes to help boost productivity

BIA welcomes the release of the AMR Industry Alliance’s first progress report

The BIA today welcomes the release of the AMR Industry Alliance’s first progress report assessing the action being taken to tackle antimicrobial resistance.

BIA responds to MHRA update on Brexit preparations

The BIA has today responded to an update from the Medicines and Healthcare products Regulatory Agency (MHRA) to pharmaceutical companies on preparations for exiting the European Union.

BIA intervenes in Supreme Court case of critical importance to the bioscience sector

The UK Bioindustry Association (BIA) has been granted permission by the Supreme Court to intervene in its review of Warner-Lambert Company LLC v Generics (UK) Ltd and Actavis. The review will examine the issue of “plausibility” in patent law and could potentially impact the amount of data and evidence required before an invention can be patented. The BIA has intervened in the case to highlight the importance of the issue to the UK’s bioscience sector.

Best practice guide for communicating R&D progress to investors and the public

The UK BioIndustry Association (BIA) has today (Thursday 4 January) launched a new guide to help bioscience companies communicate their R&D clearly and effectively to investors and the public. The guide has been launched as the UK sector prepares to attend one of the world’s largest biotech conferences: the 36th annual JP Morgan Healthcare Conference.

Parkinson’s UK is named BIA Charity of the Year for 2018

The BioIndustry Association (BIA) has today announced that Parkinson’s UK will be its official Charity of the Year for 2018. The partnership will be formally launched at the upcoming BIA Gala Dinner on 25 January 2018.

Life science coalition launches a joint policy document on the potential impact of the United Kingdom’s exit from the European Union.

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exit the European Union.

“Safeguarding public health must be number one priority” for EU27 and UK Government in phase two of Brexit talks

To coincide with today’s House of Commons Health Select Committee on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’, the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have published new research on the public health implications of Brexit.